CytomX Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of CTMX for the last quarter is 41.46 M USD, and it's 55.83% higher compared to the previous quarter. The net income of Q1 24 is 13.79 M USD.